Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Verrica Pharmaceuticals Inc. (VRCA) had Weighted-Average Shares Outstanding (Diluted) of 5.18M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.57M |
|
$-76.58M |
|
$2.74M |
|
$4.83M |
|
$73.48M |
|
$-65.92M |
|
$-10.66M |
|
$-76.58M |
|
$-76.58M |
|
$-76.58M |
|
$-76.58M |
|
$-76.58M |
|
$-76.58M |
|
$-65.92M |
|
$-64.65M |
|
5.18M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.18M |
$-14.80 |
|
$-14.80 |
|
| Balance Sheet Financials | |
$51.18M |
|
$0.59M |
|
$2.96M |
|
$54.13M |
|
$29.01M |
|
$31.75M |
|
$34.98M |
|
$63.99M |
|
$-9.86M |
|
$-9.86M |
|
$-9.86M |
|
9.18M |
|
| Cash Flow Statement Financials | |
$-60.93M |
|
$-0.02M |
|
$37.73M |
|
$69.55M |
|
$46.33M |
|
$-23.22M |
|
$7.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.76 |
|
-- |
|
-- |
|
1.45 |
|
-4.57 |
|
63.79% |
|
-871.25% |
|
-871.25% |
|
-854.48% |
|
-1012.15% |
|
-1012.15% |
|
$-60.95M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.11 |
|
98.26 |
|
3.71 |
|
776.66% |
|
776.66% |
|
-141.46% |
|
-349.82% |
|
$-1.07 |
|
$-11.76 |
|
$-11.76 |
|